Note that Baxdela was approved by the FDA today for ABSSSI. It appears to be directed particularly at difficult to manage patients, with co-morbidities.
Yet they have not landed a US pharma licensing deal.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
